Is ketosis observed in von Gierke disease (glycogen storage disease type I), and if so, what is the mechanism; if not, why is it absent?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ketosis in Von Gierke Disease (GSD Type I)

Ketosis is characteristically ABSENT or minimal in von Gierke disease (GSD Type I), which is a key distinguishing feature from other glycogen storage diseases. 1, 2

Why Ketosis Does NOT Occur in GSD Type I

The absence of significant ketosis in von Gierke disease is due to the underlying metabolic defect:

  • Impaired gluconeogenesis blocks ketogenesis: In GSD Type I, the deficiency of glucose-6-phosphatase prevents the final step of both gluconeogenesis AND glycogenolysis. This metabolic block results in accumulation of glucose-6-phosphate, which is shunted into glycolysis, producing excessive lactate 2

  • Lactate elevation predominates over ketones: As blood glucose drops below 70 mg/dL (4 mmol/L), blood lactate concentrations rise rapidly in GSD I, becoming markedly elevated when glucose falls below 40-50 mg/dL (2.2-2.8 mmol/L). In contrast, β-hydroxybutyrate levels increase only modestly 2

  • The metabolic pathway is redirected: The excess glucose-6-phosphate cannot be converted to free glucose, so it is metabolized through alternative pathways that produce lactate rather than ketone bodies

Clinical Significance: A Diagnostic Distinguishing Feature

The "lack of severe ketones" is explicitly listed as a distinguishing feature of GSD Type I when differentiating it from other glycogen storage diseases 1, 2:

Key Differential Points:

  • GSD Type I: Hypoglycemia + marked lactic acidosis + minimal ketosis + elevated uric acid
  • GSD Type III, VI, IX: Hypoglycemia + marked hyperketonemia + normal lactate + normal uric acid 1, 2

During Fasting Studies:

A controlled fasting study clearly demonstrates this difference:

  • GSD Type I: Blood lactate rises rapidly as hypoglycemia develops, with minimal ketone production
  • GSD Type III: Hyperketonemia with fasting is the hallmark finding 1

Common Pitfall to Avoid

Do not confuse the metabolic profile of GSD Type I with other hepatic GSDs. If you see significant ketosis with fasting hypoglycemia in a patient with hepatomegaly, this argues AGAINST GSD Type I and suggests GSD Type III, VI, or IX instead 1, 2. The presence of marked ketosis should prompt investigation for these alternative diagnoses, as they have intact gluconeogenesis that allows ketone body production during fasting states.

The research evidence confirms that in non-ketotic GSD patients (Type I), no excess dicarboxylic acids are excreted, further supporting that ketosis is not a feature of this disease 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.